ERBB2 and breast carcinoma: Age, race, TNM stages, tumor grades, estrogen receptor (ER)/progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) overexpression were found to be independent prognostic factors in female breast cancer, according to multivariate Cox regression and competing risks analyses.